Govt begins anti-dumping probe against antibiotic Metronidazole imported from China

The applicant is the major producer of metronidazole in India.

394
Govt of India
Govt of India

Last Updated on January 9, 2024 by The Health Master

The Union ministry of commerce and industry has initiated an anti-dumping investigation against antibiotic metronidazole imported from China following a complaint filed by Aarti Drugs Limited.

Metronidazole is used in the treatment of bacterial infections and parasitic infections. It is used in cases of amoebiasis (amoebic dysentery), trichomoniasis (STD), giardiasis (beaver fever), gingivitis (gum inflammation), acute ulcerative, anaerobic vaginosis (vaginal inflammation) caused by an overgrowth of natural bacterial found in the tracts.

The product, an intermediate compound 2-Methyl 5-Nitro Imidazole undergoes a condensation process with ethylene oxide in the presence of formic acid (85 percent) and sulphuric acid (98 percent).

An esterification reaction is carried out with methanol which generates methyl formate (methyl methanoate).

This esterification reaction is mass precipitated with liquor ammonia at the rate (of 24 percent)] to isolate the unreacted 2-MNI.

This isolated 2-MNI is dried and reused in the process. The washing mother liquor is transferred to a multiple-effect evaporator for recovery of ammonium sulfate and mixed glycol.

The filtered cake is transferred for separation, wherein caustic soda flakes and ice mix is used to isolate the crude metronidazole.

The wet crude metronidazole is decolorized with the help of charcoal and is further crystallized to isolate metronidazole.

This isolated metronidazole is filtered. The wet material is dried in the drier, unloaded, and labeled as dry pure metronidazole.

The probe is being conducted by the ministry’s investigation arm Directorate General of Trade Remedies (DGTR).

The domestic company Aarti Drugs Limited has filed an application before the DGTR seeking an anti-dumping probe concerning imports of metronidazole from China.

The applicant has alleged that material injury is being caused to the domestic industry due to the alleged dumped imports, originating in or exported from China, and has requested the imposition of anti-dumping duties on the imports of the subject goods from China.

The applicant is the major producer of metronidazole in India.

Another producer is Unichem Laboratories which does not sell the product in India and exports its entire production.

The applicant claimed that its performance has been severely impacted in the form of low production, sales, and market share and significant losses, cash losses, and a negative return on capital employed.

The applicant said that the Chinese producers must be asked to demonstrate that their costs and price information are market-driven and if they are not complying with this, the normal value should be calculated as per the prevailing rules.

On the basis of the duly substantiated written application by or on behalf of the domestic industry, and having satisfied itself, on the basis of the prima facie evidence submitted about the dumping, the DGTR has initiated the investigations, according to a notification of the directorate on October 4, 2022.

The proposed period of investigation is from April 2021 to March 2022. The injury investigation period for the present investigation will be 2018-2021 and period of investigation.

The DGTR has invited information related to the investigation within thirty days from the date of receipt of the notice.

Any party making any confidential submission or providing information on a confidential basis before the Authority is required to simultaneously submit a non-confidential version of the same.

NPPA extends price revision of Heparin injection, LMO and Oxygen inhalation

This eye drop might replace reading glasses soon

Govt introduces registration certificate for sales of Medical Devices

USFDA gives final approval for Brivaracetam tablets

Unichem recalls 18,960 bottles of this hypertension drug

Doctors urge FDA to add miscarriage management to abortion pill label

NPPA fixes Retail Prices of 40 Formulations: September 2022

IPC launches 1000th IP Reference Standard

NDPS: Inter-state Pharmaceutical drug racket busted

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news